Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of acute phase reaction after first zoledronate infusion
ACTRN12624001403527Phase 4Not yet recruiting
- Sponsor
- The University of Auckland
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone, acetaminophen and zoledronate in osteoporosis (4 arms), sponsored by The University of Auckland. Primary endpoint: Mean greatest temperature change from baseline. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
dexamethasoneacetaminophenzoledronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ACTRN12624001403527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001403527.